Archive


Category: ~$32.5M

  • AcelRx to Acquire Lowell for ~$32.5M

    Shots: AcelRx signs a merger agreement to acquire Lowell for $32.5M in cash and an additional ~$26.0M in contingent consideration upon the achievement of regulatory and sales-based milestones, $3.5M in AcelRx common stock, ~$6.5M is expected to be issued to Lowell security holders at closing. The transaction is expected to close in Q4’21 The acquisition […]